{"schema_version":"secwatch.filing_event.v1","accession":"0001171843-26-005686","form_type":"8-K","ticker":"EDSA","cik":"0001540159","company_name":"Edesa Biotech, Inc.","filed_at":"2026-08-20T20:15:17+00:00","discovered_at":"2026-08-20T20:16:00.385396+00:00","generated_at":"2026-08-20T20:16:09.567782+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Edesa Biotech prices $25.0M public offering of shares and warrants","bullets":["Offering: 3,870,500 common shares plus warrants and 675,000 pre-funded warrants; combined price $5.50 per share/warrant unit.","Gross proceeds ~$25.0M, net ~$23.1M after fees; expected close Aug 21, 2026.","Common share warrants exercisable at $7.50, expire 18 months or 30 days after Phase 2 vitiligo topline data for EB06.","Underwriters granted 30-day option for 681,825 additional shares and warrants.","Proceeds for general corporate purposes incl. working capital, R&D and manufacturing."],"urls":{"canonical":"https://secwatch.observer/filing/0001171843-26-005686","json":"https://secwatch.observer/filing/0001171843-26-005686.json","markdown":"https://secwatch.observer/filing/0001171843-26-005686.md","text":"https://secwatch.observer/filing/0001171843-26-005686.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/0001171843-26-005686-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1540159/000117184326005686/f8k_081726.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-20T20:16:09.567782+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}